Recurrence-Associated Long Non-coding RNA Signature for Determining the Risk of Recurrence in Patients with Colon Cancer
Patients with colon cancer are often faced a high risk of disease recurrence within 5 years of treatment that is the major cause of cancer mortality. Reliable molecular markers were required to improve the most effective personalized therapy. Here, we identified a recurrence-associated six-lncRNA (l...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2018-09-01
|
| Series: | Molecular Therapy: Nucleic Acids |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2162253118301343 |
| _version_ | 1811224712474263552 |
|---|---|
| author | Meng Zhou Long Hu Zicheng Zhang Nan Wu Jie Sun Jianzhong Su |
| author_facet | Meng Zhou Long Hu Zicheng Zhang Nan Wu Jie Sun Jianzhong Su |
| author_sort | Meng Zhou |
| collection | DOAJ |
| description | Patients with colon cancer are often faced a high risk of disease recurrence within 5 years of treatment that is the major cause of cancer mortality. Reliable molecular markers were required to improve the most effective personalized therapy. Here, we identified a recurrence-associated six-lncRNA (long non-coding RNA) signature (LINC0184, AC105243.1, LOC101928168, ILF3-AS1, MIR31HG, and AC006329.1) that can effectively distinguish between high and low risk of cancer recurrence from 389 patients of a discovery dataset, and validated its robust performance in four independent datasets comprising a total of 906 colon cancer patients. We found that the six-lncRNA signature was an independent predictive factor of disease recurrence in multivariate analysis and was superior to the performance of clinical factors and known gene signature. Furthermore, in silico functional analysis showed that the six-lncRNA-signature-associated coding genes are significantly enriched in proliferation and angiogenesis, cell death, as well as critical cancer pathways that could play important roles in colon cancer recurrence. Together, the six-lncRNA signature holds great potential for recurrence risk assessment and personalized management of colon cancer patients. Keywords: colon cancer, long non-coding RNAs, recurrence, signature |
| first_indexed | 2024-04-12T08:53:52Z |
| format | Article |
| id | doaj.art-5210785282ba405bb91c3c51ddf981d8 |
| institution | Directory Open Access Journal |
| issn | 2162-2531 |
| language | English |
| last_indexed | 2024-04-12T08:53:52Z |
| publishDate | 2018-09-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Molecular Therapy: Nucleic Acids |
| spelling | doaj.art-5210785282ba405bb91c3c51ddf981d82022-12-22T03:39:30ZengElsevierMolecular Therapy: Nucleic Acids2162-25312018-09-0112518529Recurrence-Associated Long Non-coding RNA Signature for Determining the Risk of Recurrence in Patients with Colon CancerMeng Zhou0Long Hu1Zicheng Zhang2Nan Wu3Jie Sun4Jianzhong Su5School of Ophthalmology & Optometry and Eye Hospital, School of Biomedical Engineering, Wenzhou Medical University, Wenzhou 325027, ChinaCollege of Bioinformatics Science and Technology, Harbin Medical University, Harbin 150081, ChinaCollege of Bioinformatics Science and Technology, Harbin Medical University, Harbin 150081, ChinaDepartment of Orthopedic Surgery, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100730, ChinaSchool of Ophthalmology & Optometry and Eye Hospital, School of Biomedical Engineering, Wenzhou Medical University, Wenzhou 325027, China; Corresponding author: Jie Sun, School of Ophthalmology & Optometry and Eye Hospital, School of Biomedical Engineering, Wenzhou Medical University, Wenzhou 325027, China.School of Ophthalmology & Optometry and Eye Hospital, School of Biomedical Engineering, Wenzhou Medical University, Wenzhou 325027, China; Corresponding author: Jianzhong Su, School of Ophthalmology & Optometry and Eye Hospital, School of Biomedical Engineering, Wenzhou Medical University, Wenzhou 325027, China.Patients with colon cancer are often faced a high risk of disease recurrence within 5 years of treatment that is the major cause of cancer mortality. Reliable molecular markers were required to improve the most effective personalized therapy. Here, we identified a recurrence-associated six-lncRNA (long non-coding RNA) signature (LINC0184, AC105243.1, LOC101928168, ILF3-AS1, MIR31HG, and AC006329.1) that can effectively distinguish between high and low risk of cancer recurrence from 389 patients of a discovery dataset, and validated its robust performance in four independent datasets comprising a total of 906 colon cancer patients. We found that the six-lncRNA signature was an independent predictive factor of disease recurrence in multivariate analysis and was superior to the performance of clinical factors and known gene signature. Furthermore, in silico functional analysis showed that the six-lncRNA-signature-associated coding genes are significantly enriched in proliferation and angiogenesis, cell death, as well as critical cancer pathways that could play important roles in colon cancer recurrence. Together, the six-lncRNA signature holds great potential for recurrence risk assessment and personalized management of colon cancer patients. Keywords: colon cancer, long non-coding RNAs, recurrence, signaturehttp://www.sciencedirect.com/science/article/pii/S2162253118301343 |
| spellingShingle | Meng Zhou Long Hu Zicheng Zhang Nan Wu Jie Sun Jianzhong Su Recurrence-Associated Long Non-coding RNA Signature for Determining the Risk of Recurrence in Patients with Colon Cancer Molecular Therapy: Nucleic Acids |
| title | Recurrence-Associated Long Non-coding RNA Signature for Determining the Risk of Recurrence in Patients with Colon Cancer |
| title_full | Recurrence-Associated Long Non-coding RNA Signature for Determining the Risk of Recurrence in Patients with Colon Cancer |
| title_fullStr | Recurrence-Associated Long Non-coding RNA Signature for Determining the Risk of Recurrence in Patients with Colon Cancer |
| title_full_unstemmed | Recurrence-Associated Long Non-coding RNA Signature for Determining the Risk of Recurrence in Patients with Colon Cancer |
| title_short | Recurrence-Associated Long Non-coding RNA Signature for Determining the Risk of Recurrence in Patients with Colon Cancer |
| title_sort | recurrence associated long non coding rna signature for determining the risk of recurrence in patients with colon cancer |
| url | http://www.sciencedirect.com/science/article/pii/S2162253118301343 |
| work_keys_str_mv | AT mengzhou recurrenceassociatedlongnoncodingrnasignaturefordeterminingtheriskofrecurrenceinpatientswithcoloncancer AT longhu recurrenceassociatedlongnoncodingrnasignaturefordeterminingtheriskofrecurrenceinpatientswithcoloncancer AT zichengzhang recurrenceassociatedlongnoncodingrnasignaturefordeterminingtheriskofrecurrenceinpatientswithcoloncancer AT nanwu recurrenceassociatedlongnoncodingrnasignaturefordeterminingtheriskofrecurrenceinpatientswithcoloncancer AT jiesun recurrenceassociatedlongnoncodingrnasignaturefordeterminingtheriskofrecurrenceinpatientswithcoloncancer AT jianzhongsu recurrenceassociatedlongnoncodingrnasignaturefordeterminingtheriskofrecurrenceinpatientswithcoloncancer |